Ibrutinib, Acalabrutinib, Zanubrutinib Clinical Trials

1 actively recruiting trial across 1 location

Also known as: IMBRUVICA, CALQUENCE, BRUKINSA

Filter by location:

San Francisco, California1 trial

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

San Francisco VA Medical Center, San Francisco, CA

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.